As there is no reliable evidence of its benefits or long-term effects, its impossible to say how safe or effective this practice is
Tirzepatide es un medicamento inyectable aprobado por la FDA para el tratamiento de la diabetes tipo 2 (bajo el nombre comercial Mounjaro) y para el manejo del peso en adultos con obesidad o sobrepeso (como Zepbound)
Dig deeper: For official compounder lists, safety alerts, and updates on regulatory classifications, check the federal guidelines directly on the FDA official website at fda.gov
One clinical trial evaluated the effects of KD on obesity, psoriasis, and psoriatic arthritis (205)
Best for: People with 30+ pounds to lose, those who struggle with constant hunger, emotional eaters, people with insulin resistance or pre-diabetes